tabularasa Revenue and Competitors
Estimated Revenue & Valuation
- tabularasa's estimated annual revenue is currently $1.7M per year.
- tabularasa's estimated revenue per employee is $106,250
Employee Data
- tabularasa has 16 Employees.
- tabularasa grew their employee count by -11% last year.
tabularasa's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Founder | Reveal Email/Phone |
2 | Community Manager | Reveal Email/Phone |
3 | Managing Partner | Reveal Email/Phone |
tabularasa Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $3.5M | 18 | 0% | N/A | N/A |
#2 | N/A | 19 | -21% | N/A | N/A |
#3 | $7.5M | 57 | 21% | N/A | N/A |
#4 | $11830M | 36 | 44% | $1M | N/A |
#5 | $7.5M | 48 | 50% | $48.1M | N/A |
#6 | $15M | 123 | 17% | N/A | N/A |
#7 | N/A | 8 | -88% | N/A | N/A |
#8 | N/A | 24 | -11% | N/A | N/A |
#9 | N/A | 16 | 14% | N/A | N/A |
#10 | $7.5M | 53 | 20% | N/A | N/A |
What Is tabularasa?
We are building a Venture Capital firm focused on opportunistic investing in the psychedelics space. While many psychedelics are not currently legalized, our research and time within the industry has shown us that the likelihood of legalization over the next 2 years is extremely high. With multiple compounds already in phase III trials, and Ketamine recently released for sale as a nasal spray by Johnson and Johnson, we believe that psychedelics are the next frontier of both medical as well as recreationally available substances/pharmaceuticals.
keywords:N/A
N/A
Total Funding
16
Number of Employees
$1.7M
Revenue (est)
-11%
Employee Growth %
N/A
Valuation
N/A
Accelerator
tabularasa News
Tabula Rasa HealthCare Inc (TRHC) Stock Falls -6.07% This Week; Should You Buy? Friday, April 22, 2022 10:56 AM | InvestorsObserver Analysts.
All of these theories and traumas are nestled in Matryoshka, the season-two closer. Nadia spends much of the season trying to fix the past and...
A portfolio company of BlackRock fund (NYSE: BLK) intends to make a proposal to transact with certain non-core assets of Tabula Rasa...
Other Companies in New York
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $1.4M | 16 | -11% | N/A |
#2 | $2M | 16 | 14% | N/A |
#3 | $0.6M | 16 | -6% | $27.1M |
#4 | $1.1M | 16 | 220% | $128.5M |
#5 | $0.5M | 16 | -11% | $29M |